Literature DB >> 19414739

Cutting edge: Negative regulation of dendritic cells through acetylation of the nonhistone protein STAT-3.

Yaping Sun1, Y Eugene Chin, Elizabeth Weisiger, Chelsea Malter, Isao Tawara, Tomomi Toubai, Erin Gatza, Paolo Mascagni, Charles A Dinarello, Pavan Reddy.   

Abstract

Histone deacetylase (HDAC) inhibition modulates dendritic cell (DC) functions and regulates experimental graft-vs-host disease and other immune-mediated diseases. The mechanisms by which HDAC inhibition modulates immune responses remain largely unknown. STAT-3 is a transcription factor shown to negatively regulate DC functions. In this study we report that HDAC inhibition acetylates and activates STAT-3, which regulates DCs by promoting the transcription of IDO. These findings demonstrate a novel functional role for posttranslational modification of STAT-3 through acetylation and provide mechanistic insights into HDAC inhibition-mediated immunoregulation by induction of IDO.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19414739      PMCID: PMC6232841          DOI: 10.4049/jimmunol.0804388

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

Review 1.  Stats: multifaceted regulators of transcription.

Authors:  Melissa M Brierley; Eleanor N Fish
Journal:  J Interferon Cytokine Res       Date:  2005-12       Impact factor: 2.607

2.  Stat3 dimerization regulated by reversible acetylation of a single lysine residue.

Authors:  Zheng-Long Yuan; Ying-Jie Guan; Devasis Chatterjee; Y Eugene Chin
Journal:  Science       Date:  2005-01-14       Impact factor: 47.728

3.  Functional relevance of the conserved DNA-binding domain of STAT2.

Authors:  Melissa M Brierley; Eleanor N Fish
Journal:  J Biol Chem       Date:  2005-01-24       Impact factor: 5.157

4.  Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function.

Authors:  Jennifer L Brogdon; Yongyao Xu; Susanne J Szabo; Shaojian An; Francis Buxton; Dalia Cohen; Qian Huang
Journal:  Blood       Date:  2006-09-28       Impact factor: 22.113

5.  Activation of Stat3 sequence-specific DNA binding and transcription by p300/CREB-binding protein-mediated acetylation.

Authors:  Rui Wang; Pratima Cherukuri; Jianyuan Luo
Journal:  J Biol Chem       Date:  2005-01-13       Impact factor: 5.157

6.  Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.

Authors:  Michelle A Blaskovich; Jiazhi Sun; Alan Cantor; James Turkson; Richard Jove; Saïd M Sebti
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

7.  Histone hyperacetylation is associated with amelioration of experimental colitis in mice.

Authors:  Rainer Glauben; Arvind Batra; Inka Fedke; Martin Zeitz; Hans A Lehr; Flavio Leoni; Paolo Mascagni; Giamila Fantuzzi; Charles A Dinarello; Britta Siegmund
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

Review 8.  STAT3: an important regulator of multiple cytokine functions.

Authors:  Stanislaw M Stepkowski; Wenhao Chen; Jeremy A Ross; Zsuzsanna S Nagy; Robert A Kirken
Journal:  Transplantation       Date:  2008-05-27       Impact factor: 4.939

9.  The histone deacetylase inhibitor ITF2357 reduces production of pro-inflammatory cytokines in vitro and systemic inflammation in vivo.

Authors:  Flavio Leoni; Gianluca Fossati; Eli C Lewis; Jae-Kwon Lee; Giulia Porro; Paolo Pagani; Daniela Modena; Maria Lusia Moras; Pietro Pozzi; Leonid L Reznikov; Britta Siegmund; Giamila Fantuzzi; Charles A Dinarello; Paolo Mascagni
Journal:  Mol Med       Date:  2005 Jan-Dec       Impact factor: 6.354

10.  Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment.

Authors:  Konrad A Bode; Kate Schroder; David A Hume; Timothy Ravasi; Klaus Heeg; Matthew J Sweet; Alexander H Dalpke
Journal:  Immunology       Date:  2007-07-16       Impact factor: 7.397

View more
  67 in total

1.  Increased EGFR expression induced by a novel oncogene, CUG2, confers resistance to doxorubicin through Stat1-HDAC4 signaling.

Authors:  Sirichat Kaowinn; Seung Won Jun; Chang Seok Kim; Dong-Myeong Shin; Yoon-Hwae Hwang; Kyujung Kim; Bosung Shin; Chutima Kaewpiboon; Hyeon Hee Jeong; Sang Seok Koh; Oliver H Krämer; Randal N Johnston; Young-Hwa Chung
Journal:  Cell Oncol (Dordr)       Date:  2017-08-03       Impact factor: 6.730

Review 2.  Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity.

Authors:  Elizabeth O Stenger; Hēth R Turnquist; Markus Y Mapara; Angus W Thomson
Journal:  Blood       Date:  2012-03-07       Impact factor: 22.113

3.  Editorial: HDAC inhibition begets more MDSCs.

Authors:  Pavan Reddy
Journal:  J Leukoc Biol       Date:  2012-05       Impact factor: 4.962

Review 4.  Modifying radiation damage.

Authors:  Kwanghee Kim; William H McBride
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

5.  Neddylation plays an important role in the regulation of murine and human dendritic cell function.

Authors:  Nathan Mathewson; Tomomi Toubai; Steven Kapeles; Yaping Sun; Katherine Oravecz-Wilson; Hiroya Tamaki; Ying Wang; Guoqing Hou; Yi Sun; Pavan Reddy
Journal:  Blood       Date:  2013-07-17       Impact factor: 22.113

Review 6.  DLL4+ dendritic cells: Key regulators of Notch Signaling in effector T cell responses.

Authors:  Lijun Meng; Shaoyan Hu; Jian Wang; Shan He; Yi Zhang
Journal:  Pharmacol Res       Date:  2016-09-14       Impact factor: 7.658

Review 7.  Next generation treatment of acute graft-versus-host disease.

Authors:  J Magenau; P Reddy
Journal:  Leukemia       Date:  2014-06-18       Impact factor: 11.528

8.  Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases.

Authors:  M Thorn; P Guha; M Cunetta; N J Espat; G Miller; R P Junghans; S C Katz
Journal:  Cancer Gene Ther       Date:  2016-05-20       Impact factor: 5.987

Review 9.  Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases.

Authors:  Xiaoyu Hu; Lionel B Ivashkiv
Journal:  Immunity       Date:  2009-10-16       Impact factor: 31.745

10.  The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor.

Authors:  Chongren Tang; Yuhua Liu; Peter S Kessler; Ashley M Vaughan; John F Oram
Journal:  J Biol Chem       Date:  2009-09-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.